Two Sigma Investments, LP Marker Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.24 - $4.58 $9,132 - $174,287	-38,054 Reduced 70.53%	15,899 $4,000
Q3 2022 Nov 14, 2022	SELL	$0.3 - $3.73 $36,365 - $452,139	-121,217 Reduced 69.2%	53,953 $20,000
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.46 $20,942 - $37,052	-80,549 Reduced 31.5%	175,170 $58,000
Q1 2022 May 16, 2022	SELL	$0.37 - $1.0 $121,499 - $328,377	-328,377 Reduced 56.22%	255,719 $113,000
Q4 2021 Feb 14, 2022	SELL	$0.95 - $1.72 $287,767 - $521,010	-302,913 Reduced 34.15%	584,096 $555,000
Q3 2021 Nov 15, 2021	SELL	$1.68 - $2.88 $190,375 - $326,358	-113,319 Reduced 11.33%	887,009 $1.5 Million
Q2 2021 Aug 16, 2021	BUY	$1.88 - $3.56 $1.68 Million - $3.17 Million	891,128 Added 816.05%	1,000,328 $2.79 Million
Q1 2021 May 17, 2021	BUY	$1.47 - $3.29 $160,524 - $359,268	109,200 New	109,200 $245,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $201M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.